Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma

J Natl Cancer Inst. 1990 Feb 7;82(3):235-8. doi: 10.1093/jnci/82.3.235.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Drug Evaluation
  • Humans
  • Interferon Type I / administration & dosage*
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Lymphoma, Non-Hodgkin / therapy*
  • Middle Aged
  • Recombinant Proteins

Substances

  • Interferon Type I
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins